Lecture Overview
Lumbar total disc replacement (TDR) is no longer experimental: it is proven, reproducible, and superior to fusion for appropriately selected patients.
Drawing on FDA Investigational Device Exemption (IDE) trial data, long-term randomised controlled trials, and international registry outcomes, the historical objections to disc replacement are no longer relevant. The evidence base for TDR is among the strongest in spinal surgery.
Mr McKenna — the UK's leading practitioner of lumbar disc arthroplasty — has been performing disc replacements since 2003 and consistently advocates for motion-preserving surgery where clinically appropriate.
Summary of Key Arguments
Five-year data from multiple FDA IDE randomised controlled trials — the highest regulatory scrutiny ever applied to a new spinal technology — consistently show TDR is non-inferior or superior to fusion across pain scores, disability indices, and patient satisfaction. This evidence is not preliminary; it is mature and reproducible across multiple independent study groups and device types.
Meta-analysis of five-year RCT data demonstrated a 48% relative reduction in reoperation risk for TDR compared with fusion. Patients undergoing disc arthroplasty were significantly less likely to require further surgery at the index level or adjacent levels — a finding consistent across all commercially approved devices.
The single greatest long-term failure mode of lumbar fusion is adjacent segment disease (ASD) — accelerated degeneration of the disc immediately above or below the fusion, driven by abnormal compensatory loading. By preserving motion at the treated level, disc replacement eliminates the biomechanical environment that causes ASD, protecting the patient's spine for decades to come.
Early concerns that the anterior surgical approach required for disc replacement carried unacceptable vascular risk have not been borne out. Post-market surveillance data mandated by the FDA shows perioperative morbidity for lumbar arthroplasty is no worse than — and in several analyses better than — anterior lumbar interbody fusion (ALIF), the comparable fusion technique.
Across RCTs, patients who underwent TDR consistently reported higher satisfaction rates than those who received fusion. Analysis showed a statistically significant 13% relative improvement in patient satisfaction favouring TDR (RR 1.13; 95% CI 1.03–1.24). Patients return to activity faster and report better functional outcomes at 5 years.
First-generation concerns about implant longevity, subsidence, and late failure have been addressed by modern device engineering. Current implants — including the LP-ESP, Baguera-L, and activL used by Mr McKenna — feature anatomical sizing, hydroxyapatite-coated titanium endplates for osseointegration, and mobile-bearing designs that replicate the instantaneous axis of rotation of the natural disc.
The Evidence at a Glance
Sources: Zigler J, Gornet MF et al. Global Spine Journal 2018; FDA IDE trial data 2007–2019; post-market surveillance reports.
Patient Selection
Comparison
| Total Disc Replacement | Lumbar Fusion (ALIF/PLIF) | |
|---|---|---|
| Principle | Motion preservation — replaces the disc with an articulating implant | Motion elimination — permanently fuses two vertebrae |
| Adjacent Segment Risk | Significantly reduced — maintains natural loading | 2–3% per year after 5 years; leading cause of reoperation |
| Reoperation Rate (5yr) | ~48% lower than fusion in RCTs | Higher; fusion remains the baseline comparator |
| Recovery Time | Faster — no bone graft healing required | Longer — 3–6 months for bone to fully fuse |
| Mobility | Full segmental motion maintained | Permanent loss of motion at fused segment |
| Patient Satisfaction | Higher at 5 years in RCTs | Good, but consistently lower than TDR in head-to-head trials |
| Evidence Base | FDA IDE RCTs; 5–10yr follow-up available | Extensive — decades of long-term data |
| Applicability | Specific patient selection required | Broader indications including deformity, instability, tumour |
Mr Patrick McKenna at discreplacement.co.uk endorses the evidence-based approach to disc arthroplasty presented herein. Mr McKenna has been performing lumbar and cervical disc replacements since 2003 and brings over two decades of specialist expertise to every case.